A protein called MYOF may help glioblastoma grow
Original title: Uncovering MYOF as a novel therapeutic target in glioblastoma: mechanistic insights and drug discovery.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was only done in cells and in animals, not in people.
The short version
In lab and animal tests, blocking a protein called MYOF slowed brain tumor growth.
What was studied. Researchers looked at glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, the most common cancerous brain tumor that starts in the brain. They lowered the amount of a protein called MYOF in tumor cells and in animals, and they tested a small molecule called Entacapone that targets MYOF.
What they found. Turning down MYOF strongly slowed glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary growth in cells and in animals. The team found that MYOF helps move a growth signal called STAT3 into the control center of the cell. Entacapone latched onto MYOF, blocked that step, and slowed glioma growth in the test models.
What this means, and what it doesn't
What it could mean: This points to a possible new target for brain tumor drugs. It gives researchers a specific protein to aim at, and one compound that seems to hit it in the lab.
What it doesn't mean: This does not mean there is a new treatment available. The work was done in cells and in animals, not in people. Entacapone was not tested against brain tumors in patients here, so we do not know if it is safe or helpful for them. This is early science, far from everyday care, and it is not a cure.
Source: PubMed, July 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.